Johnson & Johnson

organization · 1 episode · JSON

ep 82 2014-05-17 2,586 words · 13 min read The Next Big Thing In Drugs; As If You Needed Another NYT Opinion; Experience This; The Value Of The Thing … the article is hilarious because it states that "The company will start by copying Enbrel (an arthritis therapy by Amgen Inc.) and Remicade (Johnson & Johnson’s autoimmune disease …